Strategy

Mar 03, 2014
Pharmaceutical Executive
Profitability now depends on metrics to help companies answer a key strategic question: "stay the course" with more investment in sales and marketing? Or "stand down" and deploy those scarce assets somewhere else?
Feb 01, 2014
Pharmaceutical Executive
Millennium Takeda's new president, Anna Protopapas, explains the life choices that brought her from Cyprus to Cambridge—and a lead position in the hotly contested search to make cancer a treatable disease.
Jan 21, 2014
Pharmaceutical Executive
By Pharmaceutical Executive Editors
Successful innovation now has to align with key metrics of value—can an old baseball metaphor help guide the way?
Jan 21, 2014
Pharmaceutical Executive
For Big Pharma, the merits of strategic focus and operational discipline are more important than ever. It is time to be decisive; muddling through is so yesterday.
Nov 25, 2013
Pharmaceutical Executive
Pharm Exec convenes a diverse panel of experts to identify the key markers of common ground: its time, people, and money against that greatest intangible—hope.
Oct 09, 2013
Real-world pharmacoeconomic data can provide critical insight for maximizing US market access and oncology product differentiation, and should be central to the overall brand strategy of any oncology product
Oct 01, 2013
Pharmaceutical Executive
New drug delivery mechanisms and devices are an opportunity to build relationship with the ultimate customer: the patient.
Sep 01, 2013
Pharmaceutical Executive
By Pharmaceutical Executive Editors
With their knowledge of molecular genetics, Pathologists are transforming the way healthcare is provided.
Sep 01, 2013
Pharmaceutical Executive
By Pharmaceutical Executive Editors
Companies are leveraging combinations of drugs and other products to gain competitive advantage and market share.
Sep 01, 2013
Pharmaceutical Executive
What it takes for promotional review teams to function at their best and avoid costly mistakes.
native1_300x100
lorem ipsum